Summary We studied the relation between tumour vascular density and tumour growth rate, metastatic incidence and vascular permeability factor (VPF) mRNA levels in a human xenograft model described previously. Vascular density was determined by automated image analysis.
As in any other living tissue, tumours require a blood supply sufficient for their maintenance and growth. In addition to delivering of oxygen and nutrients to the tumour, the tumour vasculature also functions as an escape route for metastasizing tumour cells. In 1971, Folkman postulated that solid tumours are dependent on angiogenesis for sustained growth (Folkman, 1971) . Later studies suggested that tumours possessing the capacity to induce angiogenesis and neovascularization may be associated with a malignant phenotype [reviewed by Liotta et al (1991) and Weinstat-Saslow and Steeg (1994) ]. In accordance with this view, the vascular density of a number of tumour types has been described recently to be predictive for the metastatic capacity of the primary tumour, and tumour angiogenesis is nowadays recognized as an important factor in tumour biology (Folkman, 1995a, b) . A correlation between high vascular density and the occurrence of metastases and poor clinical prognosis has been reported for breast cancer (Weidner et al, 1991; Horak et al, 1992) , prostate cancer (Wakui et al, 1992; Bigler et al, 1993; Weidner et al, 1993) , non-small-cell lung carcinoma (Macchiarini et al, 1992) , malignant melanoma (Srivastava et al, 1988; Smolle et al, 1989; Graham et al, 1994) and many other types of malignancies (recently reviewed by Weidner (1995) , although in the case of malignant melanoma there is controversy (Barnhill et al, 1994; Busam et al, 1995) . The mechanisms that a tumour can employ to increase the number of blood vessels are diverse and not completely understood. Angiogenesis involves the breakdown of the basal lamina that surrounds a blood vessel, migration and proliferation of endothelial cells, and organization of a new vessel structure.
Tumour-derived factors can influence each of these steps (Folkman and Shing, 1992; Albelda, 1993) . The most prominent feature that facilitates angiogenesis is the production of angiogenic factors by tumour cells. So far, about 20 factors that influence in vitro and/or in vivo aspects of angiogenesis have been reported (Folkman and Klagsbrun, 1987; Klagsbrun and D'Amore, 1991) . Among the most effective of these factors are the fibroblast growth factors (aFGF and bFGF) and vascular permeability factor (VPF, also known as vascular endothelial growth factor or VEGF) (Potgens et al, 1995a) . The ability of a tumour to form metastases depends on its expression of proteases that degrade extracellular matrix, in particular the basal lamina surrounding blood vessels, and the expression of adhesion molecules that enable tumour cells to adhere to either components of the stroma and basal lamina or to endothelial cells.
We studied the relation between tumour angiogenesis and metastatic potential of human malignant melanoma in a previously described xenograft model (Van Muijen et al, 1991a,b) . The model consists of a panel of cultured melanoma cell lines, which form a local tumour after subcutaneous injection into nude mice. The resulting xenografts differ in growth rate and in capacity to form spontaneous lung metastases. In this paper we correlate the xenograft (micro)vascular density with metastatic behaviour, the in vivo and in vitro growth rates of the melanoma cell lines and the expression level of VPF mRNA.
562 JR Westphal et al (DMEM) with glutamine (Biowhittaker, Walkersville, MD, USA), supplemented with 10% fetal calf serum (FCS) (Integro, Zaandam, The Netherlands) and antibiotics in Nunc culture flasks (Roskilde, Denmark). During our experiments, we found large numbers of metastases in the lungs of numerous mice inoculated with 1F6 cells, whereas this cell line had only sporadically given rise to metastases previously. When repeating the experiments with an old stock of 1F6 we found no lung metastases, indicating the spontaneous conversion of 1F6 towards a metastasizing phenotype. We therefore designated the mutant cell line lF6m. To determine whether 1F6 and lF6m indeed shared the same genetic background, the length of eight different hypervariable CA repeats on different chromosomal loci was determined by specific PCR on DNA isolated from both 1F6 and lF6m, as described previously (Nelen et al, 1994) . The number of CA repeats on all investigated loci was identical (data not shown). These data indicate that both cell lines have a common genetic background, and that lF6m is a true descendant from 1F6.
Mice and xenografting procedure
Human melanoma cell lines were xenografted in BALB/C nu/nu mice kept under aseptic conditions. Cultured cells were detached from the culture flask by treatment with a trypsin/EDTA/glucose solution, washed with phosphate-buffered saline (PBS) and injected s.c. into the flank of the mice in a volume of 100 gl of PBS. At least 50 mice per cell line were inoculated in total and killed at different time points after take of the primary tumour. To obtain 100% tumour take, high numbers of cells (3 x 106 for BLM, MV3, MVl and M14, 4 x 106 for IF6, lF6m and Mel57, and 5 x 106 for 530) were injected. Tumour take was determined by palpation of the inoculation site. The volume of the s.c. tumour at autopsy was estimated by multiplying length, width and height of the tumour mass. The s.c. tumour and parts of spleen and liver were removed and fixed in formalin. The lungs were perfused with a 1:5 mixture of water and Tissuetec (Miles Diagnostics Division, Elkhart, IN, USA), and formalin fixed. Parts of the tumour and the lungs were snap-frozen and stored in liquid nitrogen. No metastases were ever observed in tissue sections of spleen and liver.
Determination of metastatic burden Tissue cross-sections of formalin-fixed lungs were cut at two levels (at about one-third and two-thirds of the height of the lungs), stained with haematoxylin and eosin, and scored microscopically for the presence of lung metastases. The number of metastases was determined, and the area of the lung sections and of the metastases was measured with the aid of semiquantitative image analysis system (MOP Videoplan, Kontron, Eching, Germany). Metastatic burden was defined as the area occupied by metastases in relation to the total area of the lung sections.
Staining and quantitation of tumour vasculature Vessels in melanoma xenografts were stained immunohistochemically and quantified using an interactive automated image analysis system, as described elsewhere (van der Laak et al, submitted for publication). Briefly, frozen tissue sections were incubated with rat anti-mouse endothelial cell MAb 9F1 (a generous gift from Dr A Hamann, Hamburg, Germany), followed by an alkaline phosphatase-labelled secondary antibody. After colour development, microscopic images were recorded by a video camera with a 1Ox objective. Stained vessels were recognized by the VIDASP'us image analysis system (Kontron), with the aid of specially developed software. After interactive correction for staining irregularities, the mean vascular density could be determined for each tumour section. Between 3.2 and 10 mm2 of viable tumour tissue per section was analysed.
MTT assay
In vitro growth rates of melanoma cell lines were determined with the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) cell proliferation kit (Boehringer Mannheim, Mannheim, Germany). The MTT assay was calibrated by performing an MTT assay and a conventional cell proliferation assay (performed by direct counting of cell numbers with the aid of a Coulter counter) in a parallel fashion. Both assays resulted in similar proliferation curves (data not shown). The MTT assay was performed according to the manufacturer's instructions. Briefly, cells were cultured for different periods of time in 100 ,l of culture medium in 96-well microtitre plates (Costar, Cambridge, MA, USA) before addition of 10 p1 of 5 mg MTT per ml of PBS solution. After an incubation period of 4 h, 100 gl of lysis buffer (10% SDS/0.01 N hydrochloric acid) was added to each well. The presence of tetrazolium salt was measured spectrophotometrically at 540 nm, with 690 nm as reference wavelength.
RT-PCR for VPFNEGF mRNA Total RNA was isolated from cultured melanoma cell lines with an isolation kit purchased from Qiagen (Chatsworth, CA, USA). Conversion of VPFNEGF mRNA to cDNA was performed using a specific antisense primer (5'-TTCCTCCTGCCCGGCTCACCG-3') and avian myeloblastosis virus (AMV) reverse transcriptase (Promega, Madison, WI, USA). Subsequently, 35 PCR cycles were performed with the above-mentioned primer and 5'-CCCG-GTCGGGCCTCCGAAACCA-3' as sense primer, at an annealing temperature of 68°C. This procedure resulted in three bands of 500, 610 and 670 bp on agarose gel, corresponding to the mRNA species coding for VPF'21, VPF'65 and VPF'89 respectively. The specificity of the RT-PCR procedure was checked by blotting the PCR products on nitrocellulose and probing this blot with a fulllength VPF165 cDNA probe. All three PCR products reacted strongly with this probe, but not with cDNA probes for bFGF or IGF-I (data not shown).
Quantitative RT-PCR Quantification of the PCR products was performed basically as described by Mentzel et al (submitted for publication) for the quantification of aminopeptidase A (APA) mRNA. Briefly, a 250-bp fragment was deleted from the VPF165 cDNA. The truncated fragment was cloned into a vector containing SP6 and T7 RNA polymerase start sites using the Invitrogen TA cloning kit (San Diego, CA, USA). The insert of this construct can be amplified with the original primer combination, resulting in a 350-bp product. After determination of the insert orientation by restriction analysis, synthetic sense mutant RNA was produced using the appropriate RNA polymerase. Various concentrations of this synthetic competitor RNA were mixed with a fixed amount of sample (cell line) RNA (1 tg per reaction), and RT-PCRs were Angiogenesis in human melanoma xenografts 563 performed as described above. In these reactions, the synthetic RNA competed with the wild-type RNA for enzymes and nucleotides, resulting in the formation of decreasing amounts of wild-type PCR products with increasing amounts of mutant (competitor) RNA. Wild-type PCR products and mutant PCR product were separated on agarose gel (the mutant product being 150 bp smaller than the smallest wild-type product), and stained with ethidium bromide. The intensities of the stained bands were measured. The amount of VPF mRNA in the sample RNA was quantified by determining the concentration of synthetic RNA in which the intensity of the mutant product band equalled the sum of the intensities of the bands of the wild-type products.
Statistical analysis
Non-linear (in vivo growth rates of xenografts) and linear (relation MVD and tumour age or tumour volume; calibration curves of quantitative RT-PCR for VPF mRNA) regression analysis was performed with the aid of the GraphPad Prism software package (GraphPad Software, San Diego, CA, USA). Mean vascular density values of the xenografts were evaluated with Dunn's multiple comparisons test, and in vitro VPF mRNA levels with the Tukey-Kramer multiple comparisons test.
RESULTS

Vascularization of melanoma xenografts
We analysed the vasculature of xenografts of the different cell lines by staining tumour tissue sections with 9F1, a rat monoclonal antibody directed against mouse endothelial cells. To confirm the endothelial cell (EC)-specificity of MAb 9F1, we compared 9F1 staining of tissue sections of several normal mouse tissues and melanoma xenografts with the staining by anti-mouse endothelium-specific MAb MEC 7.46 raised and characterized by Vecchi et al (1994) . In normal mouse tissues, 9F1 was less specific for endothelial cells than MEC 7.46, but in xenograft sections 9F1 reacted only with endothelial cells (data not shown). We chose 9F1 for further analysis because 9F1 stained ECs with a higher intensity than MEC 7.46, which was of importance for the subsequent image analysis process. Representative examples of M14 and MV3 xenografts stained with 9F1 are shown in Figure 1 . Viable tumour tissue in xenografts from all the cell lines was almost exclusively confined to the periphery of the tumour, especially in tumours larger than 1 cm3. Observations were therefore confined to this region of the tumours. In xenografts derived from cell lines 1F6, lF6m, MV1, M14 and Mel57, the number of vessels per area unit was low compared with BLM and MV3 tumours. The vessels were relatively large, and were surrounded by a cuff of viable tumour tissue. These viable tumour 'islands' were surrounded by large necrotic areas. Xenografts of MV3 and BLM demonstrated a higher number of vessels per area unit, and necrosis in the tumour periphery was relatively rare. The percentage of small vessels in these xenografts was relatively high in relation to the total number vessels.
We quantified our observations on vessel numbers by semiautomated image analysis of tissue sections stained with 9F1. This approach enabled us not only to study the number of vessels per surface unit, but also to measure parameters such as vessel area and diameter. The results, expressed as mean vascular density (MVD), are shown in Figure 2 (1997) 76(5) Figure 2F and B respectively). The number of vessels in the 3-6 jim and the 6-9 jim diameter classes, representing the two largest vessel subsets, proved to be the most informative in discriminating between the degree of vascularization of BLM and MV3
on one hand, and 1F6, lF6m, MV1, M14 and Mel57 on the other hand ( Figure 2C and D and Table 1 ). In the 9-12 jim class the differences between BLM and MV3 xenografts, and xenografts derived from lF6m and Mel57 became less marked, but still highly significant for xenografts derived from I1F6, M 14 and MV1I ( Figure   2E , Table 1 ).
Next, we investigated whether the observed differences in (Figure 4) . After a maximum of 6 weeks, the xenografts had grown to a size when killing of the mice could no longer be postponed. A total of 530 xenografts grew relatively slowly. Most tumours were still less than 1 cm3, 2-3 months after take of the tumour. Xenografts of the other cell lines showed intermediate growth rates. Remarkably, 1F6 xenografts reached larger volumes than lF6m xenografts, despite the fact that 1F6 showed a lower in vitro proliferation rate. In the category of BLM and MV3 xenografts, no correlation was found between MVD and tumour volume or age (data not shown).
Formation of lung metastases by melanoma xenografts
The occurrence of lung metastases was determined by screening two tissue sections of lung cross-sections, one at one-third and one at two-thirds of the height of the lungs. Examination of a larger number of tissue sections from more levels of the lungs had shown that > 95% of metastasis-positive lungs were detected in this way British Journal of Cancer (1997) 76(5) Although number and size of metastases were similar among the various groups, we did observe differences in the time points after tumour take at which lung metastases were first observed. Figure 5 shows the occurrence of lung metastasis in mice carrying xenografts of different ages. As early as 10 days after take of the s.c. tumour, micrometastases could be found in mice bearing BLM xenografts. When 568 JR Westphal et al metastatic burden was very low; only one or two micrometastases per section and never more than ten tumour cells per metastatic lesion were observed. We looked for a possible correlation between the vascular density of BLM and MV3 xenografts and the presence or absence of metastases or the metastatic burden. No statisticaly significant differences could be observed between MVD values in xenografts of mice without or with lung metastases (Figure 2) . Also, no correlation was found between MVD and metastatic burden (data not shown).
Quantification of VPF mRNA in melanoma cell lines
In a previous study, we showed by Northern blot analysis that VPF is expressed by cell lines BLM and MV3, but not by cell lines 1F6 and Mel57 (Potgens et al, 1 995b) . When performing an RT-PCR to detect VPF mRNA, positivity was found in RNA samples from all cell lines (data not shown), indicating that VPF mRNA was expressed by all cell lines but in some cell lines was apparently below the detection level of Northern blot. To substantiate these findings, we developed a quantitative RT-PCR for VPF mRNA. Figure 6A shows the products of a series of RT-PCRs after separation on agarose gel and staining with ethidium bromide. After measuring the intensities of the bands, log (concentration competitor RNA) was plotted against log (ratio of band intensities) ( Figure 6B ). Only experiments with a correlation coefficient of the resulting graph > 0.95 were used. The amount of wild-type VPF mRNA in the sample RNA could be extrapolated by determining the RNA concentration at log (ratio of band intensities) = 0 ( Figure  6B ). In Figure 6C , results of mRNA concentration determination for two separate experiments are shown. The amount of mRNA in the highly vascularized cell line MV3 was significantly higher than in I F6, IF6m, Mel57, M14 (P < 0.001) and BLM (P < 0.05). VPF mRNA concentrations in BLM were significantly higher compared with those in 1F6, lF6m, M14 and Mel57 (P < 0.05).
DISCUSSION
In this paper we elaborate on a previously described xenograft model in which human melanoma cells, propagated as cell lines in vitro, are injected subcutaneously into nude mice.
We have measured the vascular densities of xenografted s.c. melanoma tumours. As opposed to most other reports on quantification of the tumour vasculature, we have used automated image analysis of a relatively large tumour area instead of manually selecting one or a few microscopic fields with the highest vascular density (the hotspot' method) as a parameter for determining the vascularity of our tumours. Although we have found (van der Laak et al, submitted for publication) that in our model there is a good correlation between the results of both methods, there are three reasons for using automated image analysis of a large tumour area instead of hot spot density measurements. First, automated image analysis allows one to include vessel parameters, such as vessel diameter in the analysis of the obtained data. As we have shown, vessels of a certain diameter (corresponding by morphological criteria to capillaries), discriminated best between the different groups of xenografts. Second, when assessing the effect of vascularization on the tumour growth rate, the vascularity of the entire tumour (the MVD) will contribute and has to be taken into account. Third, angiogenic hot spots may be more objectively determined by image analysis than by manual selection (van der Laak et al, submitted for publication). Angiogenic hot spots in a tumour may be decisive in determining the metastatic behaviour, as only part of the tumour has to be highly vascularized to increase the probability of metastasizing tumour cells to enter the bloodstream, especially if tumour cells with a metastasizing phenotype are located within this hotspot.
We found that, in BLM and MV3 xenografts, MVD values of vessels between 3 and 12 ,um were 2-4 times higher than those of the other cell lines. Analysing subclasses of vessels based on their diameter distinctly enhanced the differentiation into different degrees of vascularization. M14 showed a distinctively lower vessel density than BLM and MV3 in all investigated vessel diameter classes. In the case of Mel57, the difference was most apparent in the 3-6 ,um class, whereas 1F6 and MVl showed the most pronounced differences in the 6-12 gm class.
BLM and MV3 distinguished themselves from the other cell lines in displaying a higher in vivo growth rate, and BLM by formation of spontaneous lung metastases soon after take of the s.c. tumour (8-15 days). The number and size of the lung metastases formed in mice with M 14 or Mel57 xenografts were similar to those found in mice carrying BLM xenografts, but they appeared later after tumour take. Lack of correlation between vessel density and metastatic potential was also demonstrated by xenografts derived from 1 F6 and its spontaneous descendant lF6m. These xenografts display vascular profiles that are quantitatively and qualitatively identical, but in I F6m-bearing mice numerous spontaneous lung metastases were observed, whereas 1F6 xenografts only sporadically metastasized. We conclude that in our model system a high MVD correlates with an increased rate of in vivo proliferation and with faster metastasis formation, but not with the event of metastasis formation per se. Whether the rapid metastasis formation in BLM and MV3 xenografts is a direct consequence of the high vessel number cannot be concluded from our data. Obviously, the rapid growth rate of the xenografts results in a higher number of cells that have the opportunity to metastasize. Alternatively, the intrinsic properties of different types of tumour cells may be the cause of different metastasis formation speeds. Previous studies have shown that BLM and MV3 differ from the other cell lines with respect to factors that influence the metastatic process. They show a strong adherence to extracellular matrix components laminin and collagen types I and IV (Danen et al, 1993 , and have a high expression level of the extracellular protease urokinase-type plasminogen activator (uPA) and its inhibitor PAI-I (Quax et al, 1991; Van Muijen et al, 1995) . The formation of experimental lung metastasis may be used as an indicator of the metastasizing capacities of a cell line. This capacity was investigated by van Muijen et al (1991a) for cell lines 530, 1F6, M14, Mel57, MV3 and BLM. All lines, with the exception of 1F6, were able to form experimental lung metastases with an efficiency ranging between 50% and 90%, with the highest percentages found in mice injected with BLM or MV3. This superior intrinsic metastatic capacity of circulating BLM and MV3 cells may have contributed to the higher speed of metastasis formation we observed for these cell lines.
The relationship between vascular density and malignancy in human melanoma is currently under debate. Whereas preliminary studies indicated that microvessel density in these tumours correlated with their potential to invade and metastasize (Srivastava et al, 1988; Barnhill et al, 1992; Graham et al, 1994) , other reports could not confirm this (Carnochan et al, 1991; Barnhill et al, 1994; Busam et al, 1995 ). In our model system, there was no correlation between vascular density and the ability to metastasize as well.
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One should bear in mind, however, that s.c. human tumours that are grown in nude mice are not fully comparable to human primary melanomas with respect to location (subcutaneous vs intra(epi)dermal), origin (inoculation with a bulk of cultured cells vs mono-or oligoclonal expansion) and source of the vascular bed (mouse vs human).
Our current and previous data (Potgens et al, 1 995a) have shown that BLM and MV3 show an expression level of VPF protein and mRNA that is clearly elevated compared with the cell lines that generate poorly vascularized tumours, emphasizing the previously described role (Folkman and Klagsbrun, 1987; Leung et al, 1989; Klagsbrun and D'Amore, 1991) of this factor in the angiogenic process. Potgens et al (1995b Potgens et al ( , 1996 transfected the low VPFproducing cell line Mel57 with the VPF'2' gene, resulting in a cell line with an in vitro expression level of this VPF isoform that was 1000-fold higher than in the parental cell line. Xenografts derived from the transfected cell line showed a vascular pattern that was dramatically changed compared with parental cell line xenografts. In the parental xenografts vessels were scattered randomly throughout the tumour, whereas in the mutant xenografts tumour nodules were surrounded by highly vascularized septa. Frequency, size and time point of occurrence of spontaneous lung metastases did not differ in mice bearing either xenograft. Complementary data were recently presented by Claffey et al (1996) . Inoculation of mice with melanoma cell line SK-Mel-2 transfected with mouse VPFI64 cDNA, resulted in highly vascularized tumours with an increased growth rate compared with tumours derived from mocktransfected cells. Moreover, VPF-transfected cells showed an increased ability to form experimental lung metastases after i.v. injection. The effect of transfection with VPF on the formation of spontaneous lung metastases was not assessed in this study. As angiogenesis in unlikely to play a role in the initial take and growth of (micro)metastases, the mechanism by which VPF increased metastatic potential remains unclear. It is possible that the permeabilization effect of VPF on the vessel wall leads to a facilitated extravasation of tumour cells. This possibility, however, does not explain why increased metastatic incidence was not observed in the experiments with VPF-transfected melanoma cell lines described by Potgens et al (1996) , as VPF'2' is a potent inducer of vessel permeability. Further data on the role of VPF in angiogenesis and metastasis formation come from the observation that VPF mRNA is induced in 1F6 and Mel 57 xenografts because of hypoxic conditions (Potgens et al, 1995b) . This up-regulation, however, did not lead to increased vascular densities in 1F6 and Mel57 xenografts, it did not induce metastasis formation in 1F6 bearing mice and it did not increase speed of metastasis formation in Mel57 mice. It is reasonable to assume that also in 530, 1 F6m, M 14 and MV1 xenografts, VPF mRNA expression is up-regulated because of hypoxic conditions. In these cell lines no effect on MVD and/or speed of metastases formation was found compared with BLM and MV3. Taken together, these data show that VPF may be required for, and/or augments the vascularized phenotype and the metastatic potential of a melanoma xenograft, but may have to act in concert with one or more other (angiogenic) factors. To shed more light on this issue, we are currently investigating the expression levels of a panel of other angiogenic factors on protein and mRNA level in both the melanoma cell lines and in the corresponding xenografts.
In this paper we have analysed some aspects of tumour angiogenesis in an in vivo model for human melanoma. Although in this model a vascular bed of murine origin is generated by human angiogenic factors, rapid tumour growth and metastatic spread occur, apparently unhindered by the species barrier, thereby confirming the suitability of the model to study the process of angiogenesis. Both the vascularity of the xenografts and the metastatic burden can be easily quantified in a standardized manner. Considering the different vascular densities we found in xenografts derived from the different cell lines, this model provides us with material that is well suited to investigate the mechanisms that are responsible for this increased vascular density. Furthermore, our model may allow for testing the in vivo effects of antiangiogenic drugs on tumour growth and vascular densities in a preclinical setting. ABBREVIATIONS bFGF, basic fibroblast growth factor; EC, endothelial cell; MAb, monoclonal antibody; MVD, mean vascular density; RT-PCR, reverse transcriptase-polymerase chain reaction; VPF/VEGF, vascular permeability factor/vascular endothelial growth factor.
